CryoLife (CRY) Tops Q2 EPS by 3c, Lifts FY Revenue Guidance

CryoLife (NYSE: CRY) reported Q2 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the quarter came in at $68.5 million versus the consensus estimate of $64.08 million.

GUIDANCE:

CryoLife sees FY2018 EPS of $0.29-$0.32, versus the consensus of $0.30. CryoLife sees FY2018 revenue of $256-260 million, versus the consensus of $254.43 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c